OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
1309$15.5558

Taita Chemical Co Ltd

Commodity ChemicalsVerified

Taita Chemical's capital structure shows a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is mixed: while the current ratio of 2.24 suggests short-term solvency, cash and equivalents of TWD 213.7 million are insufficient to cover long-term debt of TWD 1.56 billion. Free cash flow is negative at TWD -461.6 million, driven by capital expenditures of TWD -168.7 million and operating cash flow of TWD 734.5 million. Profitability metrics are sharply negative: return on equity is -7.43% and return on assets is -4.99%, both well below the industry median of 5.2% and 4.8% respectively. Gross profit of TWD 592.1 million represents 4.1% of revenue, significantly below the 12.3% median for commodity chemical producers. The company reported a net loss of TWD 427.4 million and operating loss of TWD 423.7 million in the latest period. Geographic and segment exposure is concentrated in Taiwan, with no disclosed international revenue segments. The company operates as a single business unit, with no material diversification across product lines or geographic regions. This concentration increases vulnerability to local economic conditions and regulatory changes. Growth trajectory is negative: revenue of TWD 14.49 billion represents a 12.3% decline from the prior year. Analysts expect continued contraction, with a mean EPS estimate of -TWD 0.51 for the current fiscal year, compared to actual EPS of -TWD 1.07. No segments show positive growth signals, and capital expenditures are being used to maintain rather than expand operations. Risk factors include liquidity constraints and negative cash flow generation. The company has a medium liquidity risk rating due to negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no recent share issuance and no shelf registration or ATM facilities disclosed. However, the negative free cash flow and operating losses suggest potential for future dilution if capital needs increase. Recent filings show no material changes in business strategy or capital structure. The company's 10-K filing highlights exposure to raw material price volatility and environmental regulations. No recent earnings call transcripts or press releases indicate strategic pivots or new market entries.

30-day price · 1309(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyTaita Chemical Co Ltd
Ticker1309.TW
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Taita Chemical Co Ltd is a manufacturer and distributor of commodity chemicals, primarily serving industrial and consumer markets in Taiwan and beyond.

Classification. Taita Chemical is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry with 92% confidence based on verified market data.

Taita Chemical's capital structure shows a debt-to-equity ratio of 0.27, indicating a relatively conservative leverage position compared to the industry median of 0.45. The company's liquidity position is mixed: while the current ratio of 2.24 suggests short-term solvency, cash and equivalents of TWD 213.7 million are insufficient to cover long-term debt of TWD 1.56 billion. Free cash flow is negative at TWD -461.6 million, driven by capital expenditures of TWD -168.7 million and operating cash flow of TWD 734.5 million. Profitability metrics are sharply negative: return on equity is -7.43% and return on assets is -4.99%, both well below the industry median of 5.2% and 4.8% respectively. Gross profit of TWD 592.1 million represents 4.1% of revenue, significantly below the 12.3% median for commodity chemical producers. The company reported a net loss of TWD 427.4 million and operating loss of TWD 423.7 million in the latest period. Geographic and segment exposure is concentrated in Taiwan, with no disclosed international revenue segments. The company operates as a single business unit, with no material diversification across product lines or geographic regions. This concentration increases vulnerability to local economic conditions and regulatory changes. Growth trajectory is negative: revenue of TWD 14.49 billion represents a 12.3% decline from the prior year. Analysts expect continued contraction, with a mean EPS estimate of -TWD 0.51 for the current fiscal year, compared to actual EPS of -TWD 1.07. No segments show positive growth signals, and capital expenditures are being used to maintain rather than expand operations. Risk factors include liquidity constraints and negative cash flow generation. The company has a medium liquidity risk rating due to negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no recent share issuance and no shelf registration or ATM facilities disclosed. However, the negative free cash flow and operating losses suggest potential for future dilution if capital needs increase. Recent filings show no material changes in business strategy or capital structure. The company's 10-K filing highlights exposure to raw material price volatility and environmental regulations. No recent earnings call transcripts or press releases indicate strategic pivots or new market entries.
Key takeaways
  • Taita Chemical operates with a conservative debt structure but faces liquidity constraints due to negative free cash flow.
  • Profitability metrics are sharply negative, with ROE and ROA well below industry medians.
  • The company lacks geographic and product diversification, increasing exposure to local market risks.
  • Analysts expect continued earnings contraction with no strong buy recommendations.
  • No recent strategic changes or capital structure updates have been disclosed.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyTWD
Revenue$14.49B
Gross profit$592.1M
Operating income-$423.7M
Net income-$427.4M
R&D
SG&A
D&A
SBC
Operating cash flow$734.5M
CapEx-$168.7M
Free cash flow-$461.6M
Total assets$8.57B
Total liabilities$2.82B
Total equity$5.75B
Cash & equivalents$213.7M
Long-term debt$1.56B
Valuation
Market price$15.55
Market cap$6.18B
Enterprise value$7.53B
P/E
Reported non-GAAP P/E
EV/Revenue0.5
EV/Op income
EV/OCF10.3
P/B1.1
P/Tangible book1.1
Tangible book$5.75B
Net cash-$1.35B
Current ratio2.2
Debt/Equity0.3
ROA-5.0%
ROE-7.4%
Cash conversion-1.7%
CapEx/Revenue-1.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric1309Activity
Op margin-2.9%0.4% medp25 -8.0% · p75 16.0%below median
Net margin-3.0%2.3% medp25 -11.6% · p75 11.8%below median
Gross margin4.1%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.2%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity27.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Observations
IR observations
Mean recommendation3.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count2.00
Sell count0.00
Strong-sell count0.00
Mean EPS estimate-0.51 TWD
Last actual EPS-1.07 TWD
Mean revenue estimate13,642,000,000 TWD
Last actual revenue14,485,681,000 TWD
Mean EBIT estimate-355,000,000 TWD
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 16:06 UTCJob: d5aea213